This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Vallon Pharmaceuticals, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.40 |
| 52 Week High | US$2.17 |
| 52 Week Low | US$0.21 |
| Beta | -1.15 |
| 1 Month Change | -0.52% |
| 3 Month Change | 39.13% |
| 1 Year Change | -82.38% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -94.68% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| VLON | US Pharmaceuticals | Mercado US | |
|---|---|---|---|
| 7D | 10.5% | 1.1% | 0.7% |
| 1Y | -82.4% | 9.5% | 23.9% |
Rentabilidad vs. Industria: VLON underperformed the US Pharmaceuticals industry which returned 2.6% over the past year.
Rentabilidad vs. Mercado: VLON underperformed the US Market which returned -5.3% over the past year.
Volatilidad de los precios
| VLON volatility | |
|---|---|
| VLON Average Weekly Movement | 42.9% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: VLON's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: VLON's weekly volatility has increased from 29% to 43% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2018 | 2 | n/a | www.vallon-pharma.com |
Resumen de fundamentos de Vallon Pharmaceuticals, Inc.
| Estadísticas fundamentales de VLON | |
|---|---|
| Capitalización bursátil | US$5.39m |
| Beneficios(TTM) | -US$7.02m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-0.8x
Ratio precio-beneficio (PE)¿Está VLON sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de VLON | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$7.02m |
| Beneficios | -US$7.02m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.52 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado VLON a largo plazo?
Ver rendimiento hist órico y comparativa